NCT04045353

Brief Summary

The study is evaluating the effects of a standard diet to a low carbohydrate diet in obese women after having a baby. The purpose of the study is to determine if a low carbohydrate diet is associated with improvement in insulin sensitivity in postpartum women.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 5, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

December 20, 2019

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

April 18, 2023

Status Verified

April 1, 2023

Enrollment Period

2.5 years

First QC Date

August 1, 2019

Last Update Submit

April 14, 2023

Conditions

Keywords

Low carbohydrate diet

Outcome Measures

Primary Outcomes (1)

  • Change in insulin sensitivity as measured by homeostatic model assessment of insulin sensitivity.

    Homeostatic model assessment for measurement of insulin sensitivity will be computed with fasting insulin and glucose levels (fasting for at least 8 hours) with the following calculation: (glucose x insulin/22.5). This calculation is measured in molar units (mmol/L).

    Baseline, 3 months

Secondary Outcomes (6)

  • Change in insulin sensitivity as measured by homeostatic model assessment of insulin sensitivity.

    Baseline, 6 months

  • Change in weight measured in pounds.

    Baseline, 3 months

  • Change in weight measured in pounds.

    Baseline, 6 months

  • Development of diabetes postpartum as measured by 2 hour glucose tolerance test.

    3 months

  • Change in blood pressure as measured by blood pressure cuff in mmHg.

    Baseline, 3 months

  • +1 more secondary outcomes

Study Arms (3)

Standard of care

NO INTERVENTION

Subjects will receive standard counseling on obesity as part of routine postpartum care.

Low carbohydrate diet education

ACTIVE COMPARATOR

Subjects will receive educational materials regarding a low carbohydrate diet in addition to the standard counseling on obesity as part of routine postpartum care.

Behavioral: Low carbohydrate diet education

Low carbohydrate diet education with behavioral component

ACTIVE COMPARATOR

Subjects will receive in person instruction regarding a low carbohydrate diet as part of a 12 week course, in addition to receiving educational materials regarding a low carbohydrate diet and the standard counseling on obesity as part of routine postpartum care.

Behavioral: Low carbohydrate diet educationBehavioral: Low carbohydrate diet education with behavioral component

Interventions

A 200 page informational document that connects with an online application will be provided to subjects.

Low carbohydrate diet educationLow carbohydrate diet education with behavioral component

A 12 week course taught be a certified instructor will teach subjects about a low carbohydrate document. Subjects will also be given a 200 page informational document that connects with an online application.

Low carbohydrate diet education with behavioral component

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis study is limited subjects that are postpartum; therefore, can only include female participants.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Delivery at University of Texas Medical Branch
  • Body max index greater than or equal to 30 kilograms/meters squared at the final prenatal visit prior to delivery.
  • Singleton gestation.
  • Accessibility to the internet.
  • Basic understanding and comprehension of the English language to be assessed by study personnel at the time of recruitment.

You may not qualify if:

  • Diabetes mellitus on medication.
  • Serious medical condition, such as heart failure, kidney failure, or severe asthma, as determined by the principle investigator.
  • Planned pregnancy during study period.
  • Enrolled in another trial that may affect outcome.
  • Subject unlikely to be followed up after delivery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas Medical Branch

Galveston, Texas, 77555, United States

Location

Related Publications (3)

  • Morkrid K, Jenum AK, Sletner L, Vardal MH, Waage CW, Nakstad B, Vangen S, Birkeland KI. Failure to increase insulin secretory capacity during pregnancy-induced insulin resistance is associated with ethnicity and gestational diabetes. Eur J Endocrinol. 2012 Oct;167(4):579-88. doi: 10.1530/EJE-12-0452. Epub 2012 Aug 13.

    PMID: 22889687BACKGROUND
  • Rooney BL, Schauberger CW. Excess pregnancy weight gain and long-term obesity: one decade later. Obstet Gynecol. 2002 Aug;100(2):245-52. doi: 10.1016/s0029-7844(02)02125-7.

    PMID: 12151145BACKGROUND
  • Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS, Klein S. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003 May 22;348(21):2082-90. doi: 10.1056/NEJMoa022207.

    PMID: 12761365BACKGROUND

MeSH Terms

Conditions

ObesityGestational Weight GainInsulin Resistance

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsWeight GainBody Weight ChangesHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases

Study Officials

  • Sara O Jacobs, MD

    University of Texas

    PRINCIPAL INVESTIGATOR
  • Antonio Saad, MD

    University of Texas

    PRINCIPAL INVESTIGATOR
  • Ashley Salazar, WHNP

    University of Texas

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2019

First Posted

August 5, 2019

Study Start

December 20, 2019

Primary Completion

July 1, 2022

Study Completion

July 1, 2022

Last Updated

April 18, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations